Stock Movers: Ventyx Rises on Eli Lilly Deal, Mobileye Acquires Robot Maker, Strategy Shares Climb

Ventyx Biosciences Acquisition Rumors

• 🚀 Ventyx Biosciences (VTYX) shares surged significantly, potentially driven by reports of Eli Lilly advanced talks to acquire the company for over $1 billion.
• 💡 Eli Lilly aims to expand its immunology work, as some of its existing inflammatory disease treatments are nearing patent expiration.
• ⚠️ These acquisition talks are unconfirmed reports, but the timing is notable ahead of the JP Morgan Health Care Conference, a key event for dealmaking.

Mobileye Global's Robotics Expansion

• 🤖 Mobileye Global (MBLY) is acquiring Israeli startup Mentee Robotics for $900 million in a cash-and-stock deal.
• 🚗 This acquisition aims to expand Mobileye's robotics capabilities, aligning with a trend of automakers investing in humanoid robots for tasks like auto assembly.

Strategy (MSTR) Stock Performance

• 📈 Strategy (MSTR), formerly Micro Strategy, saw its shares climb, despite a significant slump in the past year.
• 📊 This rise is attributed to MSCI's decision to temporarily keep digital asset treasury companies within its stock market indexes, though a broader consultation may lead to future changes.